About
Why we built it.
Everyone deserves to see what’s happening inside their own body.
Origin story
The two signals nobody captures together.
LifeLeaf is built by LifePlus, a team spanning science and healthcare.
Semiconductors, signal processing, AI and physiology are an unusual combination. It is why we spend our time on the hard part.
The two signals that tell you most about how you’re doing today — nobody captures together. Blood sugar means a needle or a patch you replace every two weeks. Blood pressure means a cuff you have to stop and put on.
So most people go years without seeing either one, and find out what their body has been doing from a number read off a chart in a room with a paper-covered table.
We spent ten years on the part that makes the alternative possible: separating a real physiological signal from the noise of an ordinary day — movement, daylight, sweat, temperature — on a device small enough to forget you’re wearing.
LifeLeaf is what that work produced. It doesn’t diagnose, treat or manage any medical condition. It shows you what your body did today, and what moved it.
Team
The people behind it.
Alodeep Sanyal, PhD
Co-founder & Chief Executive Officer
Principal architect at Intel, where he led test architecture for Intel's first AI processor.
Benjamin Mbouombouo, MSEE
Co-founder & Chief Operating Officer
System chip architect at Broadcom and LSI Logic across two decades. Co-inventor on 39 issued US patents.
Jyoti Palaniappan, MBA/MPH
Chief Business Officer
Eleven years inside Abbott Diabetes Care. Before that McKinsey and Thermo Fisher; one exit.
Nilanjan Banerjee, PhD
Chief Scientific Officer
Biosensor signal processing. Professor of Computer Science, University of Maryland. Co-author on the validation studies.
Indranil Sen-Gupta, MD
Chief Medical Officer
Clinical faculty in neurology, UC Irvine. Co-author on the validation studies.
Alberto Gutierrez, PhD
Chief Regulatory Advisor
Formerly Director of the Office of In Vitro Diagnostics and Radiological Health at CDRH, FDA.
Patents
LifePlus holds 11 granted patents, with 5 pending and 4 in progress — covering how the wrist signal is captured, cleaned and read.
A team that has spent two decades in chip and signal-processing design, holding over 50 issued US patents between them.
Clinical advisory board
Who checked the work.
Independent clinicians in endocrinology, cardiology, electrophysiology, critical care and regenerative medicine.
Timothy Bailey, MD, FACE, CPI
Endocrinology
Founder, AMCR Institute, Escondido, CA. Lead author on both glucose validation studies.
Sam Asirvatham, MD, FACC
Cardiology & electrophysiology
Professor of Medicine, Cardiovascular Medicine, Mayo Clinic. Named investigator on the arterial-line study.
Wael Al Mahmeed, MD
Cardiology
Heart & Vascular Institute, Cleveland Clinic Abu Dhabi. Lead author on the cuff study.
Jerome S. Fischer, MD
Endocrinology
Former partner, Diabetes & Glandular Disease Clinic, San Antonio, Texas. Co-author on both glucose studies.
SV Mahadevan, MD
Emergency medicine
Stanford University.
Chandan Sen, PhD
Regenerative medicine
University of Pittsburgh.
In their words
What two of our advisors have said.
Independent clinical assessment, not a company claim.
The results presented at ADA this year show that LifeLeaf has the potential to provide accurate data, without invasiveness or complexity. This kind of non-invasive monitoring is uniquely poised to improve patient adherence and enable earlier detection — two critical factors in managing chronic conditions.
Timothy Bailey, MD, FACE, CPI
Abbott/Dexcom investigator
LifeLeaf delivers clinically validated performance without the usual barriers of needles, cuffs, or cost. By making blood pressure and glucose monitoring effortless and non-invasive, it drives better patient adherence, which is crucial for managing chronic conditions like hypertension and diabetes. This scalable solution has a strong potential to transform care models globally by enabling proactive, patient-friendly disease management.
Sam Asirvatham, MD, FACC
Cardiovascular Medicine, Mayo Clinic
These are the advisors’ own assessments of study results, not a claim by LifePlus. LifeLeaf is a general wellness device — it is not intended to diagnose, treat, cure or prevent any disease.
Board
Who drives the corporate governance.
Alodeep Sanyal
Board member
Co-founder & Chief Executive Officer, LifePlus.
Benjamin Mbouombouo
Board member
Co-founder & Chief Operating Officer, LifePlus.
Arnab Debnath
Board member
Investor, advisor, mentor.
Arjun Malhotra
Board member
Co-founder of HCL. Former chief executive of HeadStrong.
How do I get it
Join the waitlist.
We’ll email you launch updates and the moment Kickstarter opens at the end of October. Deep‑discount packages are limited and go first-come, first-served.
Free to join — or reserve now for $2 to lock founder pricing.